1. Home
  2. DCI vs VALN Comparison

DCI vs VALN Comparison

Compare DCI & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Donaldson Company Inc.

DCI

Donaldson Company Inc.

HOLD

Current Price

$109.26

Market Cap

11.7B

Sector

Industrials

ML Signal

HOLD

Logo Valneva SE

VALN

Valneva SE

HOLD

Current Price

$9.95

Market Cap

855.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DCI
VALN
Founded
1915
2012
Country
United States
France
Employees
N/A
N/A
Industry
Pollution Control Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.7B
855.8M
IPO Year
1987
2021

Fundamental Metrics

Financial Performance
Metric
DCI
VALN
Price
$109.26
$9.95
Analyst Decision
Buy
Strong Buy
Analyst Count
5
4
Target Price
$98.60
$15.75
AVG Volume (30 Days)
766.3K
13.0K
Earning Date
02-26-2026
03-19-2026
Dividend Yield
1.09%
N/A
EPS Growth
N/A
N/A
EPS
3.21
N/A
Revenue
$3,726,200,000.00
$211,089,992.00
Revenue This Year
$4.69
$3.64
Revenue Next Year
$4.94
$12.23
P/E Ratio
$34.29
N/A
Revenue Growth
2.37
13.48
52 Week Low
$57.45
$5.43
52 Week High
$112.84
$12.25

Technical Indicators

Market Signals
Indicator
DCI
VALN
Relative Strength Index (RSI) 75.35 58.89
Support Level $109.74 $9.53
Resistance Level $112.84 $10.40
Average True Range (ATR) 2.09 0.28
MACD 0.33 0.04
Stochastic Oscillator 80.46 77.92

Price Performance

Historical Comparison
DCI
VALN

About DCI Donaldson Company Inc.

Donaldson is a leading manufacturer of filtration systems and replacement parts (including air filtration systems, liquid filtration systems, and dust, fume, and mist collectors). The company serves a diverse range of end markets, including construction, mining, agriculture, truck, and industrial. Its business is organized into three segments: mobile solutions, industrial solutions, and life sciences. Donaldson generated approximately $3.7 billion in revenue in its fiscal 2025.

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Share on Social Networks: